8, 2022 – BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October ... the company’s CEO and co-founder, said during the earnings call. BioNTech and Pfizer ...

CEO and Co-Founder of BioNTech. On hundred million vaccine doses of the Omicron booster based on the earlier BA.1 variant have already been pre-produced by BioNTech. The vaccine is currently ...

Pfizer and BioNTech said Friday that ... labeled the strain with the Greek letter omicron. In an emailed statement to FOX Business, Pfizer said the vaccine-makers are "remaining vigilant ...

"I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild ...

Half of the Moderna vaccine targets the original 2020 virus and half the Omicron variant, which is officially known as BA.1.

Pfizer CEO Albert Bourla on Monday disclosed that he has tested positive for COVID-19 and will be going into isolation while ...

In a call today, CEO Uğur Şahin said the results ... The company said it expects deliveries for its Omicron-adapted vaccine to begin as soon as October. BioNTech today outlined plans to launch ...

Second quarter revenues of €3.2 billion1, net profit of €1.7 billion and fully diluted earnings per share of €6.45 ($6.872) as well as first half 2022 revenues of €9.6 billion, net profit ...

German vaccine developer BioNTech could deliver its COVID-19 vaccines adapted to the Omicron BA.1 and BA.4/5 sub variants in October if given regulatory approval. Together with its U.S. partner Pfizer ...

LONDON: The UK's drug regulator said on Monday (Aug 15) it had approved an updated Moderna vaccine against the coronavirus ...

Second quarter revenues of €3.2 billion1, net profit of €1.7 billion and fully diluted earnings per share of €6.45 ($6.872) as well as first half 2022 revenues of €9.6 billion, net profit of €5.4 ...